Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells

[1]  Xiao‐Kang Li,et al.  β-glucan from Aureobasidium pullulans augments the anti-tumor immune responses through activated tumor-associated dendritic cells. , 2021, International immunopharmacology.

[2]  F. Ginhoux,et al.  TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses , 2021, Nature Communications.

[3]  Jarred M. Whitlock,et al.  Flagging fusion: Phosphatidylserine signaling in cell–cell fusion , 2021, The Journal of biological chemistry.

[4]  Allon M. Klein,et al.  Tumor-infiltrating dendritic cell states are conserved across solid human cancers , 2020, The Journal of experimental medicine.

[5]  C. Sautès-Fridman,et al.  Dendritic cells in the tumor microenvironment: prognostic and theranostic impact. , 2020, Seminars in immunology.

[6]  Xiaojun Liu,et al.  Tim-4 in Health and Disease: Friend or Foe? , 2020, Frontiers in Immunology.

[7]  Leaf Huang,et al.  Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies , 2020, Theranostics.

[8]  Yongling Ning,et al.  Key genes and pathways in tumor‐educated dendritic cells by bioinformatical analysis , 2020, Microbiology and immunology.

[9]  Fiorella Kotsias,et al.  Antigen processing and presentation. , 2019, International review of cell and molecular biology.

[10]  J. Bluestone,et al.  Revisiting IL-2: Biology and therapeutic prospects , 2018, Science Immunology.

[11]  J. Rossjohn,et al.  Phospholipid signaling in innate immune cells. , 2018, The Journal of clinical investigation.

[12]  Jian-guo Li,et al.  CD80 and CD86 knockdown in dendritic cells regulates Th1/Th2 cytokine production in asthmatic mice. , 2016, Experimental and therapeutic medicine.

[13]  S. Senju,et al.  IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age , 2015, Nature Communications.

[14]  Taku Kambayashi,et al.  Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? , 2014, Nature Reviews Immunology.

[15]  D. Vance,et al.  The Concentration of Phosphatidylethanolamine in Mitochondria Can Modulate ATP Production and Glucose Metabolism in Mice , 2014, Diabetes.

[16]  Pierre Validire,et al.  Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. , 2014, Cancer research.

[17]  C. Sakamoto,et al.  Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells , 2013, Immunology and cell biology.

[18]  T. Satoh,et al.  Emulsified Phosphatidylserine, Simple and Effective Peptide Carrier for Induction of Potent Epitope-Specific T Cell Responses , 2013, PloS one.

[19]  V. Kuchroo,et al.  IL-12 family cytokines: immunological playmakers , 2012, Nature Immunology.

[20]  A. M. Rauwerdink,et al.  Ovarian cancer progression is controlled by phenotypic changes in dendritic cells , 2012, The Journal of experimental medicine.

[21]  M. Wright,et al.  Inflammatory mediators hold the key to dendritic cell suppression and tumor progression. , 2011, Current medicinal chemistry.

[22]  G. Kroemer,et al.  Prognostic and predictive impact of intra- and peritumoral immune infiltrates. , 2011, Cancer research.

[23]  Xianqun Fan,et al.  Efficient identification of phosphatidylserine-binding proteins by ORF phage display. , 2009, Biochemical and biophysical research communications.

[24]  J. Vance,et al.  Defining the Importance of Phosphatidylserine Synthase-1 (PSS1) , 2008, Journal of Biological Chemistry.

[25]  G. Freeman,et al.  TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. , 2007, Immunity.

[26]  J. Gregg,et al.  Exposure of Myeloid Dendritic Cells to Exogenous or Endogenous IL-10 during Maturation Determines Their Longevity1 , 2007, The Journal of Immunology.

[27]  D. Smrz,et al.  Non-apoptotic Phosphatidylserine Externalization Induced by Engagement of Glycosylphosphatidylinositol-anchored Proteins* , 2007, Journal of Biological Chemistry.

[28]  A. Mackensen,et al.  Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells. , 2006, Blood.

[29]  H-Z Shi,et al.  CD28/CTLA‐4–CD80/CD86 and ICOS–B7RP‐1 costimulatory pathway in bronchial asthma , 2006, Allergy.

[30]  M. Wright,et al.  Dendritic cells: activation and maturation--applications for cancer immunotherapy. , 2005, Current medicinal chemistry.

[31]  Mitsuhiro Nishida,et al.  An Increased Adjuvanticity of Liposomes by the Inclusion of Phosphatidylserine in Immunization with Surface-Coupled Liposomal Antigen , 2005, International Archives of Allergy and Immunology.

[32]  N. Romani,et al.  High Level IL-12 Product ion by Murine Dendrit ic Cells : Upregulation via MHC Class II and CD 40 Molecules and Downregulat ion by IL-4 and IL-10 By , 2003 .

[33]  J. Keenan,et al.  Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial. , 2002, The Journal of family practice.

[34]  P. Hwu,et al.  CD40 ligand and lipopolysaccharide enhance the in vitro generation of melanoma-reactive T-cells. , 2002, Journal of immunological methods.

[35]  Ira Mellman,et al.  Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.

[36]  Richard A. Flavell,et al.  Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.

[37]  G. Schuler,et al.  High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [published erratum appears in J Exp Med 1996 Oct 1;184(4):following 1590] , 1996, The Journal of experimental medicine.

[38]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[39]  J. Berzofsky,et al.  Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. , 1996, Cellular immunology.

[40]  J. Faivre,et al.  Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[41]  V. Fadok,et al.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. , 1992, Journal of immunology.